The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Active surveillance and deferred medical treatment (ASDT) in metastatic renal cell carcinoma (mRCC): Update of a single center experience and efficacy of medical treatment.
 
Philipp Ivanyi
No Relationships to Disclose
 
Maria-Luisa Tiemann
No Relationships to Disclose
 
Viktor Grünwald
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; MSD
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; Eisai; Exelixis; Ipsen; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; PharmaMar; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Cerulean Pharma; ClinSol; Ipsen; Lilly; MSD Oncology; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Novartis (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer
 
Hendrik Eggers
No Relationships to Disclose
 
Arnold Ganser
No Relationships to Disclose
 
Christoph Reuter
No Relationships to Disclose